Refractory Chronic Cough Improvement Via NAL ER (RIVER)

Clinical trial NCT05962151 · COMPLETED

Trial details

NCT number: NCT05962151
Sponsor: Trevi Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Refractory Chronic Cough

Start date: 2023-11-30
Primary completion: 2025-01-06
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.